BackIntegra Lifesciences Holdings Overview
Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Target Price

Analysts' average 12-month price target for Integra Lifesciences Holdings is $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$16.26

Average Target Price

$20.5026.1% upside

4 analysts in the last 4 months

High: $25 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28UBS$1916.9% upsideOpen
2026-07-16Truist Financial$1916.9% upsideOpen
2026-07-08BMO Capital$1916.9% upsideOpen
2026-06-18Argus Research$2553.8% upsideOpen
2026-04-15Truist FinancialRichard Newitter$1226.2% downsideOpen
2025-10-15Truist Financial$157.7% downsideOpen
2024-10-07BTIGRyan Zimmerman$2023% upsideOpen
2024-07-30Truist FinancialRichard Newitter$2659.9% upsideOpen
2024-07-30CitigroupJoanne Wuensch$2341.5% upsideOpen
2024-07-29BTIGRyan Zimmerman$2235.3% upsideOpen
2024-07-16Truist FinancialRichard Newitter$3296.8% upsideOpen
2024-05-07Truist FinancialRichard Newitter$2553.8% upsideOpen
2024-05-07JMP SecuritiesDavid Turkaly$40146% upsideOpen
2024-05-06Wells FargoVik Chopra$2553.8% upsideOpen
2022-10-26Piper SandlerMatt O'Brien$50207.5% upsideOpen
2022-07-28Piper SandlerFY22 EPS$55238.3% upsideOpen
2021-05-20JefferiesAnthony Petrone$86428.9% upsideOpen
2021-04-29RBC CapitalShagun Singh Chadha$74355.1% upsideOpen
2021-04-29Wells FargoLarry Biegelsen$74355.1% upsideOpen

Integra Lifesciences Holdings (IART) FAQ

The latest target price for IART is $21. Investors often review this figure alongside Integra Lifesciences Holdings's historical trend and sector peers before judging valuation or financial health.

Integra Lifesciences Holdings trades near $16.26 while the consensus target sits at $21 (26.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting IART's target price ($21), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Integra Lifesciences Holdings's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.